Connecticut lawmakers on Tuesday approved medical cannabis to treat an additional five conditions, which likely will boost MMJ sales in the state.
The General Assembly’s Regulations Review Committee voted to add the conditions, including Tourette syndrome and intractable neuropathic pain.
Legislators also approved medical marijuana as a treatment for patients younger than 18 with those same two conditions.
The new regulations will now be submitted to the Secretary of the State’s Office, which will post them online and, thus, make the regulations final.
Currently, 37,080 patients are participating in Connecticut’s medical marijuana program.
Connecticut has now approved medical marijuana use for 36 conditions for adults and 10 for patients younger than 18.
Additional medical conditions are still moving through the state’s approval process.
In September, a panel of physicians recommended that chronic pain be added as a condition that could be treated with MMJ.
The 2019 Marijuana Business Factbook projects MMJ sales of $100 million-$200 million in Connecticut this year.
– Associated Press and Marijuana Business Daily
Written by John Rebchook
Marijuana Business Daily